Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.
about
Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney.Did clinical trials in which erythropoietin failed to reduce acute myocardial infarct size miss a narrow therapeutic window?EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudyThe influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI.Erythropoietin Reduces Post-PCI Arrhythmias in Patients With ST-elevation Myocardial Infarction.Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-myocardial infarction.The Systematic Evaluation of Identifying the Infarct Related Artery Utilizing Cardiac Magnetic Resonance in Patients Presenting with ST-Elevation Myocardial Infarction.Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration.Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function.Myocardial protection from ischemia-reperfusion injury post coronary revascularization.Clinical Trials Update AHA Congress 2010.
P2860
Q30486662-777AC965-D05A-4FFD-94E6-4B589C00CD22Q31056941-7FA8E2F4-67C6-4BB7-98A8-ACD8F479C37BQ33558915-CF54559B-D3B8-4E49-972E-F3CCF7D9F90BQ34193545-CA568A6D-7BCA-4CFB-A70A-CA2AEE913D52Q35705440-1634105E-5B7D-4055-AF34-4AD15197D0FBQ36127313-BB719DB1-D712-46C7-AFE4-F693D6D5431BQ36242616-8D96FCCF-6237-4893-8495-880B3A65C70BQ36364317-364D74BD-7C02-488D-A1F0-9E94A9B4C4CDQ37885482-04CF22D5-398F-43EA-9FE9-1AA1E39D29C6Q38025012-F377AFA1-A262-4D99-ACA1-B31C043911C1Q38552442-B0E248AC-FE6B-496E-9C3D-2C0330F9001BQ45867461-86631E05-729C-45DF-8316-ED4BF9B479A0
P2860
Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Design and rationale of the Re ...... ial Infarction (REVEAL) trial.
@ast
Design and rationale of the Re ...... ial Infarction (REVEAL) trial.
@en
Design and rationale of the Re ...... er Large Myocardial Infarction
@nl
type
label
Design and rationale of the Re ...... ial Infarction (REVEAL) trial.
@ast
Design and rationale of the Re ...... ial Infarction (REVEAL) trial.
@en
Design and rationale of the Re ...... er Large Myocardial Infarction
@nl
prefLabel
Design and rationale of the Re ...... ial Infarction (REVEAL) trial.
@ast
Design and rationale of the Re ...... ial Infarction (REVEAL) trial.
@en
Design and rationale of the Re ...... er Large Myocardial Infarction
@nl
P2093
P2860
P50
P1476
Design and rationale of the Re ...... ial Infarction (REVEAL) trial.
@en
P2093
Chiara Melloni
Dan L Longo
Laura Melton
Manesh R Patel
Mark Talan
Rakhi Kilaru
Raymond J Kim
Samer S Najjar
Sunil V Rao
Thomas J Povsic
P2860
P304
795-803.e2
P356
10.1016/J.AHJ.2010.09.007
P407
P577
2010-11-01T00:00:00Z